- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩89,300.00
7D
0.7%
1Y
-2.8%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩36,500.00
7D
-7.9%
1Y
29.7%
JW Shinyak
Market Cap: ₩146.9b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,295.00
7D
11.1%
1Y
45.2%
DongKoo Bio & Pharma
Market Cap: ₩101.7b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩3,770.00
7D
-8.6%
1Y
-26.7%